title: Etomidate for intubation of patients who have sepsis or septic shock--where do we go from here?
abstract: Etomidate is an intravenous induction agent that is associated with hemodynamic stability during intubation. The agent is therefore attractive for use in critically ill patients who have a high risk of hemodynamic instability during this procedure. However, etomidate causes adrenal suppression, which itself has been associated with increased mortality in critically ill patients. The ongoing debate surrounding use of etomidate is thus centered on the immediate favorable hemodynamic profile versus the long-term risks of adrenal insufficiency, particularly in patients who have severe sepsis or septic shock.
authors.forename: Donald E G
authors.initials: DE
authors.lastname: Griesdale
mesh_terms: D005045:Etomidate / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use*; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D007442:Intubation, Intratracheal / Q000009:adverse effects*; D008297:Male; D012772:Shock, Septic / Q000401:mortality*
chemical_list: D006993:Hypnotics and Sedatives; D006854:Hydrocortisone; D005045:Etomidate